A federal judge has blocked the Trump administration's effort to cut the National Institutes of Health funding for research programs at universities and medical systems.
But there is still uncertainty in the healthcare industry over the potential impact of a reduction in research projects.
Last week, the National Institutes of Health announced changes in research awards.
Experts warn this could cost jobs, delay breakthroughs and weaken Ohio's role in life sciences.
Spectrum News 1 anchors Marylee Melendez and Alexa Maslowski spoke on this issue with Eddie Pauline, president and CEO of Ohio Life Sciences, an industry trade association.
